Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$1.10
NASDAQLPCN
Open
$1.11
Change
-$0.02 (-1.79%)
Day's Range
$1.08 - $1.12
52-Week Range
$1.03 - $2.42
Volume
353.2K
Market Cap
$97.1M